Emil J. Freireich

Affiliations: 
The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Cell Biology
Google:
"Emil Freireich"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kantarjian HM, Keating MJ, Freireich EJ. (2018) Toward the potential cure of leukemias in the next decade. Cancer
Kantarjian HM, DiNardo CD, Nogueras-Gonzalez GM, et al. (2018) Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Cancer
Aung F, DiNardo CD, Martinez F, et al. (2017) Phase II Study of Prophylactic Non-Irradiated Granulocyte Transfusions in AML Patients Receiving Induction Chemotherapy Journal of Blood Disorders & Transfusion. 8
Freireich E. (2016) Commentary on Thomas and Epstein: "Bone Marrow Transplantation in Acute Leukemia". Cancer Research. 76: 1301-2
Aung FM, Bassett R, Lichtiger B, et al. (2016) Comparison of Two Apheresis Instruments (Old vs. New) for Granulocyte Collection: A Single Institutional Experience Blood. 128: 5036-5036
Thompson PA, Tam CS, O'Brien SM, et al. (2015) Fludarabine, cyclophosphamide and rituximab achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia. Blood
Aung F, Freireich E, Lichtiger B. (2015) Does transfusion of aged red blood cells lead to adverse outcomes in Acute Myeloid Leukemia patients undergoing Hematopoietic stem cell Transplantation? Clinical Lymphoma Myeloma and Leukemia. 15: S179
Freireich EJ, Wiernik PH, Steensma DP. (2014) The leukemias: a half-century of discovery. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3463-9
Aung FM, Lichtiger B, Bassett RL, et al. (2014) Granulocyte concentrates from a single high-yield apheresis can be split to support multiple patients. Leukemia & Lymphoma. 55: 2577-83
DiNardo CD, Aung FM, Martinez F, et al. (2014) A Phase II Feasibility Study of Prophylactic White Cell Transfusions for the Prevention of Infection in AML Patients Undergoing Induction Therapy Blood. 124: 1564-1564
See more...